• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)治疗的左主干冠状动脉狭窄患者病情演变中危险因素的影响

The Impact of the Risk Factors in the Evolution of the Patients with Left Main Coronary Artery Stenosis Treated with PCI or CABG.

作者信息

Trașcă S P, Goanță E V, Târtea G C, Ciurea P L

机构信息

Department of Cardiology, Emergency County Hospital of Craiova, Romania.

Department of Physiology, University of Medicine and Pharmacy of Craiova, Romania.

出版信息

Curr Health Sci J. 2019 Jan-Mar;45(1):19-27. doi: 10.12865/CHSJ.45.01.02. Epub 2019 Mar 31.

DOI:10.12865/CHSJ.45.01.02
PMID:31297258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6592670/
Abstract

The aim of our study was to identify the cardiovascular risk factors present in patients with left main coronary artery disease (LMCAD), which influenced the progression of these patients in both percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). We performed a clinical observational descriptive study in which, during three years, we followed the evolution of 81 patients who were diagnosed with left main coronary artery disease and who were treated either by interventional revascularization by stent implantation, by surgical revascularization by performing an aortic-coronary bypass. In our study the risk factors according to which the evolution of the patients was observed were represented by diabetes, smoking, age and gender. The primary endpoint was mortality from any cause and other clinical endpoints were the reduction of left ventricular ejection fraction, symptomatic ischemic heart disease manifested by angina pectoris, non-procedural myocardial infarction or need for repeated revascularization. In our study diabetes was the risk factor that negatively influenced the evolution of patients with LMCAD treated either by PCI or by CABG for the most part, followed by smoking, male gender and age over 65 years.

摘要

我们研究的目的是确定左主干冠状动脉疾病(LMCAD)患者中存在的心血管危险因素,这些因素在经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)中均会影响这些患者的病情进展。我们进行了一项临床观察性描述性研究,在三年时间里,跟踪了81例被诊断为左主干冠状动脉疾病的患者的病情发展,这些患者接受了通过支架植入进行的介入性血运重建治疗,或通过实施主动脉-冠状动脉旁路移植术进行的外科血运重建治疗。在我们的研究中,观察患者病情发展所依据的危险因素包括糖尿病、吸烟、年龄和性别。主要终点是任何原因导致的死亡率,其他临床终点包括左心室射血分数降低、以心绞痛表现的有症状缺血性心脏病、非手术相关心肌梗死或再次血运重建的需求。在我们的研究中,糖尿病是对接受PCI或CABG治疗的LMCAD患者病情发展产生负面影响的主要危险因素,其次是吸烟、男性性别和65岁以上年龄。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/e2a1242b13bc/CHSJ-45-01-19-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/e4659190504b/CHSJ-45-01-19-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/7de0f7a402fe/CHSJ-45-01-19-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/6e9694a5663c/CHSJ-45-01-19-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/165148843e39/CHSJ-45-01-19-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/71b1951bf8e4/CHSJ-45-01-19-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/abc7134cac82/CHSJ-45-01-19-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/e2a1242b13bc/CHSJ-45-01-19-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/e4659190504b/CHSJ-45-01-19-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/7de0f7a402fe/CHSJ-45-01-19-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/6e9694a5663c/CHSJ-45-01-19-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/165148843e39/CHSJ-45-01-19-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/71b1951bf8e4/CHSJ-45-01-19-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/abc7134cac82/CHSJ-45-01-19-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b059/6592670/e2a1242b13bc/CHSJ-45-01-19-fig7.jpg

相似文献

1
The Impact of the Risk Factors in the Evolution of the Patients with Left Main Coronary Artery Stenosis Treated with PCI or CABG.经皮冠状动脉介入治疗(PCI)或冠状动脉旁路移植术(CABG)治疗的左主干冠状动脉狭窄患者病情演变中危险因素的影响
Curr Health Sci J. 2019 Jan-Mar;45(1):19-27. doi: 10.12865/CHSJ.45.01.02. Epub 2019 Mar 31.
2
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.左主干疾病行经皮冠状动脉介入治疗或冠状动脉旁路移植术后新发心房颤动:EXCEL 试验。
J Am Coll Cardiol. 2018 Feb 20;71(7):739-748. doi: 10.1016/j.jacc.2017.12.012.
3
Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.左主干病变伴糖尿病患者行旁路移植术或支架置入术治疗的比较
J Am Coll Cardiol. 2019 Apr 9;73(13):1616-1628. doi: 10.1016/j.jacc.2019.01.037.
4
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
5
Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 3-Year Clinical Outcomes Depending on SYNTAX Score.左主干冠状动脉疾病的支架与搭桥手术:根据SYNTAX评分的3年临床结果
Curr Health Sci J. 2019 Jan-Mar;45(1):87-95. doi: 10.12865/CHSJ.45.01.12. Epub 2019 Mar 31.
6
Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.左主干经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗有既往脑血管疾病患者的比较:EXCEL 试验结果。
JACC Cardiovasc Interv. 2018 Dec 24;11(24):2441-2450. doi: 10.1016/j.jcin.2018.09.008.
7
Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.男性和女性无保护左主干病变患者行冠状动脉支架置入术或旁路手术的结果:EXCEL 试验。
JACC Cardiovasc Interv. 2018 Jul 9;11(13):1234-1243. doi: 10.1016/j.jcin.2018.03.051.
8
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干狭窄患者的比较:系统评价和荟萃分析。
JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.
9
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄(NOBLE):一项前瞻性、随机、开放标签、非劣效性试验。
Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31.
10
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄:NOBLE 随机非劣效性试验的 5 年更新结果。
Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. Epub 2019 Dec 23.

引用本文的文献

1
Ultrasonographically detected hepatosteatosis independently predicts the presence and severity of coronary artery disease.超声检测到的肝脂肪变性可独立预测冠状动脉疾病的存在和严重程度。
Afr Health Sci. 2022 Jun;22(2):273-285. doi: 10.4314/ahs.v22i2.31.

本文引用的文献

1
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
EuroIntervention. 2019 Feb 20;14(14):1435-1534. doi: 10.4244/EIJY19M01_01.
2
Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club.经皮冠状动脉介入治疗左主干冠状动脉疾病:欧洲分叉俱乐部第 13 次共识文件。
EuroIntervention. 2018 May 20;14(1):112-120. doi: 10.4244/EIJ-D-18-00357.
3
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.
冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率:一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
4
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干狭窄患者的比较:系统评价和荟萃分析。
JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.
5
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄(NOBLE):一项前瞻性、随机、开放标签、非劣效性试验。
Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31.
6
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.依维莫司洗脱支架或旁路移植术治疗左主干冠状动脉疾病。
N Engl J Med. 2016 Dec 8;375(23):2223-2235. doi: 10.1056/NEJMoa1610227. Epub 2016 Oct 31.
7
Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.无保护左主干病变患者行经皮冠状动脉介入治疗或旁路手术后的结果。
J Am Coll Cardiol. 2016 Sep 6;68(10):999-1009. doi: 10.1016/j.jacc.2016.06.024.
8
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南:欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组(由10个学会的代表和特邀专家组成)由欧洲心血管预防与康复协会(EACPR)特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
9
Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.随机试验:左主干冠状动脉疾病中支架治疗与旁路手术的比较:PRECOMBAT 研究 5 年结果。
J Am Coll Cardiol. 2015 May 26;65(20):2198-206. doi: 10.1016/j.jacc.2015.03.033. Epub 2015 Mar 15.
10
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.在紫杉醇药物涂层支架与心脏搭桥术联合治疗左主干病变研究中,经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗左主干病变患者的 5 年结果。
Circulation. 2014 Jun 10;129(23):2388-94. doi: 10.1161/CIRCULATIONAHA.113.006689. Epub 2014 Apr 3.